SEC Form 4 · accession 0001615774-15-001309
CALMARE THERAPEUTICS Inc · CTTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stan Yarbro
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jun 1, 2015 · 10:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000102198
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2015 | A | 2,500 | $0.00 | A | 138,242 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $0.17 | Jan 2, 2015 | A | 10,000 | A | Jan 2, 2015 | Jan 2, 2019 | Common stock, par value $0.01 per share | 10,000 | 135,238 | D |
Explanation of responses
- F1Includes 40,000 stock options and the right to acquire an additional 95,238 shares upon conversion of $100,000 of convertible debt.